ALDEYRA THERAPEUTICSCS INC
Share · US01438T1060 · ALDX · A111X8 (XNAS)
2,83 USD
13.06.2025 22:37
Current Prices from ALDEYRA THERAPEUTICSCS INC
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
ALDX
|
USD
|
13.06.2025 22:37
|
2,83 USD
| 2,92 USD
-3,08 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | 8,43 % | 30,41 % | -59,04 % | -42,24 % | -24,13 % | -37,39 % |
Company Profile for ALDEYRA THERAPEUTICSCS INC Share
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma. The company has a license agreement with Madrigal Pharmaceuticals, Inc. for developing ADX-1612, which inhibits the protein chaperome for the treatment of inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
Company Data
Name ALDEYRA THERAPEUTICSCS INC
Company Aldeyra Therapeutics, Inc.
Symbol ALDX
Website
https://www.aldeyra.com
Primary Exchange
NASDAQ

WKN A111X8
ISIN US01438T1060
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Todd C. Brady M.D., Ph.D.
Market Capitalization 129 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 131 Hartwell Avenue, 02421 Lexington
IPO Date 2014-05-02
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | 137.F |
NASDAQ | ALDX |
More Shares
Investors who ALDEYRA THERAPEUTICSCS INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.